Cited by 621Pancreatic and Hepatic Oncology ResearchPancreatic function and diabetesMetabolism, Diabetes, and Cancer

The DOI matches its Crossref record; 36 of the 40 references it cites were found in a registry or an index.

Prevalence and Clinical Profile of Pancreatic Cancer–Associated Diabetes Mellitus

Open access

Pannala, Rahul, Leirness, Jeffery B., Bamlet, William R., Basu, Ananda, Petersen, Gloria M., Chari, Suresh T.·2008·Gastroenterology

DOI 10.1053/j.gastro.2008.01.039PMC PMC2323514

Open this paper in CoChat — free account Open PDF

Abstract

Background & aims Information on the clinical profile of pancreatic cancer (PaC) associated diabetes (DM) is limited. We compared the prevalence and clinical characteristics of DM in subjects with and without PaC.Methods We prospectively recruited 512 newly diagnosed PaC cases and 933 controls of similar age, who completed demographic and clinical questionnaires and had fasting blood glucose (FBG) levels measured at recruitment and after pancreaticoduodenectomy (n = 105). Subjects with a FBG level >126 mg/dL or who were on antidiabetic treatment were classified as having DM.Results DM was more prevalent (47% vs 7%; P < .001) and predominantly of new onset (<2-year duration) (74% vs 53%; P = .002) among cases compared with controls. Among PaC cases, those with DM (n = 243) were older (68 +/- 10 vs 64 +/- 12 years; P < .001), reported higher usual adult body mass index (30 +/- 6 vs 27 +/- 5 kg/m(2); P < .001), and had a greater frequency of family history of DM (47% vs 31%; P < .001) compared with those without DM (n = 269). After pancreaticoduodenectomy, while DM resolved in 17 of 30 patients (57%) with new-onset DM, its prevalence was unchanged in patients with long-standing DM (n = 11) (P = .009).Conclusions PaC is a powerful diabetogenic state; DM associated with PaC is often new-onset, resolves following cancer resection, and appears to be associated with conventional risk factors for DM. New-onset DM in patients with PaC is likely induced by the tumor.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1053/j.gastro.2008.01.039

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cancer Statistics, 2007
Jemal, A., Siegel, R., Ward, E., Murray, T., Xu, J., & Thun, M. J. (2007) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.57.1.43 · Cited by 7,439
The Disease Burden Associated With Overweight and Obesity
Must, A. (1999) · JAMA · doi:10.1001/jama.282.16.1523 · Cited by 4,827
Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: A prospective, controlled study in 254 affected women
Legro, R. S. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.1.165 · Cited by 1,743
Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia. Report of a WHO/IDF Consultation
Unwin, N. C. (2006) · Cited by 1,661
Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies
Huxley, R., Ansary-Moghaddam, A., Berrington de González, A., Barzi, F., & Woodward, M. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602619 · Cited by 1,105
Probability of Pancreatic Cancer Following Diabetes: A Population-Based Study
Chari, S. T., Leibson, C. L., Rabe, K. G., Ransom, J., de Andrade, M., & Petersen, G. M. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.05.007 · Cited by 603
Self-citation
Diagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2006) · Diabetes Care · doi:10.2337/dc07-s042 · Cited by 574
Pancreatic Cancer–Associated Diabetes Mellitus: Prevalence and Temporal Association With Diagnosis of Cancer
Chari, S. T., Leibson, C. L., Rabe, K. G., Timmons, L. J., Ransom, J. E., de Andrade, M., & Petersen, G. M. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.10.040 · Cited by 519
Self-citation
Diabetes and the Risk of Pancreatic Cancer
Gullo, L., Pezzilli, R., & Morselli‐Labate, A. M. (1994) · New England Journal of Medicine · doi:10.1056/nejm199407143310203 · Cited by 366
Randomized clinical trial of pylorus-preserving duodenopancreatectomy versus classical Whipple resection—long term results
Seiler, C., Wagner, M., Bachmann, T., Redaelli, C., Schmied, B. M., Uhl, W. H., Frieß, H., & Büchler, M. W. (2005) · British journal of surgery · doi:10.1002/bjs.4881 · Cited by 254

Show all 40 references

Sorted by citations

Items 501–600 of 621

Carcinoma of the Pancreas
Jesus‐Acosta, A. D., Narang, A. K., Mauro, L. A., Herman, J. M., Jaffee, E. M., & Laheru, D. A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-47674-4.00078-5 · Cited by 1
Diabetes and Cancer
Vigneri, R., & Sciacca, L. (2018) · Endocrinology · doi:10.1007/978-3-319-44433-8_12 · Cited by 1
How Should Secondary Causes of Diabetes Be Excluded?
Griffin, T. P., O’Loughlin, A., & Dinneen, S. F. (2021) · Wiley eBooks · doi:10.1002/9781119603207.ch4 · Cited by 2
Pankreaskrankheiten und Diabetes mellitus
Galonska, M., Hartje, I., & Büchsel, R. (2012) · Journal für Kardiologie (Krause & Pachernegg GmbH) · Cited by 1
Diabetes Mellitus Related to Diseases of the Exocrine Pancreas (Pancreatogenic Diabetes)
Bradley, D. A., & Hart, P. A. (2021) · Wiley eBooks · doi:10.1002/9781119570097.ch80 · Cited by 1
Güncel Cerrahi Tedavi
Aslan, A., Mert, T., Uçaner, B., Hançerlioğulları, O., Karaman, Ç., Çiftçi, M. S., Acar, S., Göktaş, S. S., Anadolulu, Z., Özkara, M., et al. (2023) · Akademisyen Kitabevi eBooks · doi:10.37609/akya.2641 · Cited by 1
Newly Diagnosed Diabetes Mellitus With Pancreatic Cancer Manifested as Hyperglycemic Hyperosmolar State
Kwon, T. H., Kim, M. S., Jeon, J. H., Jeong, D. I., Yun, S. S., & Lee, Y. K. (2013) · Journal of the Korean Geriatrics Society · doi:10.4235/jkgs.2013.17.2.95
Paraoxonase-1 (PON1) Status in Pancreatic Cancer: Relation to Clinical Parameters (pancreaticcancer/paraoxonase1(PON1)polymorphisms/PON1arylesterase/lactonaseactivities/ malnutrition)
Vecka, M., Jáchymová, M., Vávřová, L., Kodydková, J., Macášek, J., Urbánek, M., Krechler, T., Slaby, A., Duskova, J., & Muravská, A. (2012)
Inherited Genetics of Pancreatic Cancer and Secondary Screening
(2012) · SpringerReference · doi:10.1007/springerreference_72840
Diabetes mellitus y su asociación con cáncer de páncreas en el anciano: reporte de caso y revisión de la bibliografía
Cuéllar, R. A. B., Balbuena, M. M., Vera, W. X. M., de Pablo, P. A. S., & Gutiérre, P. V. (2010) · Medicina Interna de México
A Novel Anti-Diabetic Peptide Nanomedicine Against Pancreatogenic Diabetes
Banerjee, A. (2013) · Figshare
How should we treat glucose intolerance as a risk factor for pancreatic cancer?
Sato, E., Tando, Y., Yanagimachi, M., Tanaka, H., Matsuhashi, Y., Matsumoto, A., KAKIZAKI, A., Chikazawa, S., Kon, A., & Nakamura, T. (2012) · Suizo · doi:10.2958/suizo.27.139
Pancreatic cancer biomarkers discovery by surface-enhanced laser desorption and ionization time-of-flight mass
Navaglia, F., Fogar, P., Basso, D., Greco, E., Padoan, A., Fadi, E., Bozzato, D., Moz, S., Seraglia, R., Pedrazzoli, S., et al. (2009)
Reply to ‘Comment on ‘New-onset type 2 diabetes, elevated HbA1c, anti-diabetic medications, and risk of pancreatic cancer’’
Lu, Y., Rodríguez, L. A. G., Malgerud, L., González‐Pérez, A., Martín‐Pérez, M., Lagergren, J., & Bexelius, T. S. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.100
Differential Diagnosis and Diagnostic Evaluation Algorithm
Bartel, M. J., Leo, M. D., & Raimondo, M. (2015) · Springer eBooks · doi:10.1007/978-3-319-19677-0_16
Transección parenquimatosa pancreática mediante dispositivo asistido por radiofrecuencia en un modelo porcino de pancreatectomía distal laparoscópica
Dorcaratto, D. (2013) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Interactions of the receptor for advanced glycation end products (RAGE) with advanced glycation end products and S100B
Indurthi, V. S. K. (2016)
Characterizing the Metabolomic Effects of Pancreatic Cancer
Bathe, O. F. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-408103-1.00014-5
Maladies du pancréas exocrine et diabète
Larger, É., & Lemoine, A. (2013)
Risk factors and early signs of pancreatic cancer in diabetes: screening strategy based on diabetes onset age Suguru MizunoYousuke NakaiHiroyuki IsayamaAyako YanaiNaminatsu Takahara • Koji MiyabayashiKeisuke YamamotoKazumichi KawakuboDai MohriHirofumi Kogure • Takashi SasakiNatsuyo YamamotoNaoki SasahiraKenji HiranoTakeshi Tsujino •
Yanai, A., & Akanuma, M. (2013)
Pancreatogenic diabetes: etiology, implications, and management
Andersen, D. K. (2017) · Wiley eBooks · doi:10.1002/9781118924907.ch14c
Late Metabolic Complications After Pancreatectomy
Yoon, Y. (2017) · Springer eBooks · doi:10.1007/978-3-662-47181-4_34
Gastro-Highlights 2009
Rogler, G., Wirth, H.-P., Bauerfeind, P., Müllhaupt, B., Rösch, T., Schöfl, R., Schwizer, W., & Fried, M. (2009) · Die Gastroenterologie · doi:10.1007/s11377-009-0366-3
Secondary Screening for Inherited Pancreatic Ductal Adenocarcinoma
Sheel, A., Nicholson, J., Sarantitis, I., Neoptolemos, J. P., & Greenhalf, W. (2017) · Springer eBooks · doi:10.1007/978-1-4939-6631-8_63-1
New-onset hyperglycemia: A potential clue to detect early pancreatic cancer
Chakraborty, P. P., Ray, S., Mukhopadhyay, S., & Chowdhury, S. (2017) · Clinical Diabetology · doi:10.5603/dk.2017.0019
New-onset type 2 diabetes mellitus as a symptom of pancreatic cancer: case report
Caride-Miana, E., & Anguita, C. G. (2017) · Digestive System · doi:10.15761/dsj.1000109
Strengthening the research of pancreatogenic diabetes
Fu, J., & Ji, Q.-H. (2018) · Scientia Sinica Vitae · doi:10.1360/n052018-00014
Glukosestoffwechsel und Karzinom-Progress
Waggershauser, C. H. (2019) · Gastro-News · doi:10.1007/s15036-019-0526-3
Insight in disease and drug interactions, with treatment optimisation of patients with cancer
Knapen (2019) · Research Publications (Maastricht University) · doi:10.26481/dis.20190510lk
Type 2 diabetes mellitus and gastrointestinal cancer
de Jong (2019) · Research Publications (Maastricht University) · doi:10.26481/dis.20190605rj
Systemic and mucosal immunity in patients with periampullary cancer, obstructive jaundice and chronic pancreatitis
Darwish, A. (2014) · Research Explorer (The University of Manchester)
Medical Nutrition Therapy Throughout the Continuum of Care for Localized Pancreatic Cancers
Sonntag, K. (2019) · Springer eBooks · doi:10.1007/978-3-319-98944-0_14
Temporal patterns of new-onset diabetes in pancreatic cancer
Dong, W., Yu, H., Wang, Q., & Tian, Z. (2019) · World Chinese Journal of Digestology · doi:10.11569/wcjd.v27.i15.943
Loss of TIP30 Accelerates Pancreatic Cancer Progression and Metastasis
Williams, I., & Imade, E. (2019)
Molecular Mechanisms of Metabolic Reprogramming in Pancreatic Cancer
Kumari, S. (2019) · doi:10.21007/etd.cghs.2019.0482
Changes in Pancreatic Endocrine Function and Morphology After Pancreaticoduodenectomy
Yoon, H. J., Choi, J. S., Shin, W. Y., Lee, K.-Y., & Ahn, S. (2020) · Pancreas · doi:10.1097/mpa.0000000000001492
Challenges and Opportunities for Early Pancreatic Cancer Detection: Role for Protein Biomarkers
Oldfield, L. S., Barrera, L. N., Williams, D., Evans, A., Neoptolemos, J. P., & Costello, E. (2020) · Molecular and translational medicine · doi:10.1007/978-3-030-49476-6_4
High Frequency of Multiple Imaging Studies During the Diagnostic Workup for Pancreatic Ductal Adenocarcinoma
Branch, L. L., Elmunzer, B. J., Förster, E., Hoffman, B. J., Moran, R. A., & Coté, G. A. (2020) · Pancreas · doi:10.1097/mpa.0000000000001643
Pancreatic Ductal Adenocarcinoma and Type 2 Diabetes Mellitus: Distant Relatives or the Close Ones?
Subham, K., Mohanty, S., Jena, S., Ojha, M., & Jha, S. (2020) · Diagnostics and therapeutic advances in GI malignancies · doi:10.1007/978-981-15-5471-1_13
Evaluation of risk factors associated with pancreatic adenocarcinoma in Black Sea region, Turkey
Derebey, M., Karabulut, K., Yuruker, S. S., Karabıçak, İ., & Özen, N. (2021) · Experimental Biomedical Research · doi:10.30714/j-ebr.2021165780
Screening of Pancreatic Cancer for Early Diagnosis
Chang, J. H. (2021) · Korean Journal of Medicine · doi:10.3904/kjm.2021.96.2.110
Survival and Late Morbidity After Resection of Pancreatic Cancer
Nevler, A., Yeo, C. J., & Winter, J. M. (2018) · doi:10.1002/9781119188421.ch120
Elevated levels of CA 19-9 and CEA in pancreatic cancer-associated diabetes
Chen, K. Z. (2010)
On the Origin of Morphological Structures of Planetary Nebulae
Kwok, S. (2011) · The HKU Scholars Hub (University of Hong Kong)
Pancreatic Cancer Screening
Chalhoub, J. M., & Andrawes, S. (2021) · Clinical gastroenterology · doi:10.1007/978-3-030-69940-6_8
Islet Inflammation: The Link between Type 2 Diabetes and Pancreatic Cancer
Mukhuty, A. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.98538
Occurrence of Pancreatic Cancer Associated Insulin Dependent Diabetes
Sunčana, N. K. (2017) · Cancer Research and Cellular Therapeutics · doi:10.31579/2640-1053/016
Etiology and early detection of pancreatic cancer
Yu, J. (2021) · Figshare
Inherited Genetics of Pancreatic Cancer and Secondary Screening
Greenhalf, W., & Neoptolemos, J. P. (2009) · Springer eBooks · doi:10.1007/978-0-387-77498-5_51
Diabetes and Cancer
Vigneri, R., & Sciacca, L. (2018) · Endocrinology · doi:10.1007/978-3-319-27316-7_12-1
Diabetes and Cancer
Vigneri, R., & Sciacca, L. (2019) · Endocrinology · doi:10.1007/978-3-319-27316-7_12-2
Diabetes and Cancer
Vigneri, R., & Sciacca, L. (2020) · Endocrinology · doi:10.1007/978-3-030-36694-0_12
Diagnostic Biomarkers
Macgregor‐Das, A. M., & Goggins, M. (2017) · Springer eBooks · doi:10.1007/978-1-4939-6631-8_56-1
Diabète inaugural révélant un cancer pancréatique chez une femme âgée
(2018) · Batna Journal of Medical Sciences (BJMS) · doi:10.48087/bjmscr.2018.5127
Glukosestoffwechsel und Karzinomprogress
Waggershauser, C. H. (2019) · InFo Hämatologie + Onkologie · doi:10.1007/s15004-019-6560-7
New-onset type ii diabetes mellitus in early diagnosis of pancreatic cancer: literature review
Ponomarev, P. А., Евгеньевич, М. В., Pavlovsky, A. V., Popov, S. A., Turlak, A. S., & Гранов, Д. А. (2022) · Perm Medical Journal · doi:10.17816/pmj39341-54
Carbohydrate metabolism in patients after pancreatoduodenal resection
As, A., Av, S., Pashkova, E. Y., Tavobilov, M. M., Karpov, A. A., Иванович, Г. И., & Amikishieva, K. A. (2022) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2022-16-14-120-126
Diabetes rápidamente progresiva como primera manifestación de un adenocarcinoma de páncreas
Rivas-Sánchez, F. B., Romero-Masa, E., Pacheco-Yepes, M. R., Cuesta-Muñoz, A. L., & Gómez‐Huelgas, R. (2017) · Revista Española de Casos Clínicos en Medicina Interna · doi:10.32818/reccmi.a2n2a3
Lo que la diabetes esconde
Gabella-Martín, M., Cobos-Siles, M. M., Otero, J. A., & Briongos-Figuero, L. S. (2018) · Revista Española de Casos Clínicos en Medicina Interna · doi:10.32818/reccmi.a3s1a6
Ductal Adenocarcinoma and Pancreatic Intraepithelial Neoplasia
(2023) · American Registry of PathologyArlington, Virginia eBooks · doi:10.55418/9781933477275-07
The Potential Clue for Early Diagnosis of Pancreatic Cancer—New-Onset Diabetes
周, 积. (2023) · Advances in Clinical Medicine · doi:10.12677/acm.2023.133540
In Vivo, Ex Vivo and In Silico Methods to Study Pancreas Biology During Health and Disease
Weitz, J. (2023) · Journal of Visualized Experiments · doi:10.3791/64938
Data from Feasibility of Identifying Pancreatic Cancer Based on Serum Metabolomics
Bathe, O. F., Shaykhutdinov, R. A., Kopciuk, K. A., Weljie, A. M., McKay, A., Sutherland, F. R., Dixon, E., Dunse, N., Sotiropoulos, D., & Vogel, H. J. (2023) · doi:10.1158/1055-9965.c.6514944.v1
Data from Feasibility of Identifying Pancreatic Cancer Based on Serum Metabolomics
Bathe, O. F., Shaykhutdinov, R. A., Kopciuk, K. A., Weljie, A. M., McKay, A., Sutherland, F. R., Dixon, E., Dunse, N., Sotiropoulos, D., & Vogel, H. J. (2023) · doi:10.1158/1055-9965.c.6514944
Data from Plasma miRNA Biomarkers in Limited Volume Samples for Detection of Early-stage Pancreatic Cancer
Dittmar, R. L., Liu, S., Tai, M. C., Rajapakshe, K., Huang, Y., Longton, G., DeCapite, C., Hurd, M. W., Paris, P. L., Kirkwood, K. S., et al. (2023) · doi:10.1158/1940-6207.c.6547039.v1
Clinical Features and Correlation between Pancreatic Cancer and Diabetes Mellitus
周, 积. (2023) · Advances in Clinical Medicine · doi:10.12677/acm.2023.134798
Definition, Diagnostic Criteria, Screening, Diagnosis, and Classification of Diabetes and Categories of Glucose Intolerance: An Update
Nandhini, L. P., Kamalanathan, S., & Sahoo, J. (2023) · Springer eBooks · doi:10.1007/978-3-031-25519-9_6
Pancreatic Adenocarcinoma Surveillance Counterpoint: Europe
Smith, R. A., Butler, J. V., & Neoptolemos, J. P. (2012) · Humana Press eBooks · doi:10.1007/978-1-60327-969-7_24
Epidemiology of Pancreatic Cancer
Mocci, E., & Klein, A. P. (2023) · doi:10.1002/9781119876007.ch117
Survival and Late Morbidity after Resection of Pancreatic Cancer
Nevler, A., & Yeo, C. J. (2023) · doi:10.1002/9781119876007.ch156
Integrative analyses of bulk, single-cell and spatial transcriptomics identified diabetes mellitus-related signature as a prognostic factor in pancreatic adenocarcinomaPreprint
Tang, L. M., Xie, T., Fan, G., Zhu, H., Yao, J., & Shi, Y. (2023) · Research Square · doi:10.21203/rs.3.rs-3637164/v1
Early Biomarkers for Pancreatic Cancer: A Quest for Survival, Review on the Most Effective Approaches at PresentPreprint
Bestari, M. B., Joewono, I. R., & Syam, A. F. (2023) · Preprints.org · doi:10.20944/preprints202312.2276.v1
Pancreatic and Biliary Tract Cancers
Ney, A., Osei‐Bordom, D., García-Sampedro, A., Acedo, P., Fusai, G., Stott, M. C., Hopley, P. J., Patel, C., Oldfield, L. S., Greenhalf, W., et al. (2024) · Wiley eBooks · doi:10.1002/9781119756422.ch17
Diabetes mellitus and pancreatic cancer: a literature review
As, A., Pashkova, E. Y., Antsiferova, D. M., & Rumer, V. B. (2023) · Endocrinology News Opinions Training · doi:10.33029/2304-9529-2023-12-4-55-62
Mechanism exploration and biomarker identification of glycemic deterioration in patients with diseases of the exocrine pancreas
Wang, Z., Zhang, G., Fu, J., Li, G., Zhao, Z., Choe, H., Ding, K., Ma, J., Wei, J., Shang, D., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-52956-x
Pancreatic cancer-related diabetes mellitus: A retrospective investigation of clinical characteristics and relationship with the prognosisPreprint
Takaoka, T., Oono, T., Ohno, A., Murakami, M., Matsumoto, K., Teramatsu, K., Ueda, K., Fujimori, N., & Ogawa, Y. (2024) · Research Square · doi:10.21203/rs.3.rs-4088010/v1
Global research trends and hotspots between pancreatic cancer and diabetes from2004 to 2024: A bibliometric analysisPreprint
Wang, Y., Xu, C., Xu, Y., Gu, W., Lu, L., Jin, H., Jin, Z., & Zhang, X. (2024) · Research Square · doi:10.21203/rs.3.rs-4198735/v1
Impact of pancreatic cancer and tumor therapies on glucose homeostasis and on islet cell gene expression in diabetes and upon its remission in living donors
Rummeny, S., Engel, M. W., Barovic, M., Friedland, D., Kipke, N., Schöniger, E., Morgenroth, Y., Aust, D. E., Distler, M., & Solimena, M. (2024) · Diabetologie und Stoffwechsel · doi:10.1055/s-0044-1785290
External UK validation of the ENDPAC model to predict pancreatic cancer risk: A registered report protocolPreprint
Price, C. A., Claridge, H., de Lusignan, S., Khalaf, N. I., Mold, F., Smith, N. A. S., Winn, M., & Lemańska, A. (2024) · medRxiv · doi:10.1101/2024.05.21.24307690 · Cited by 1
Using Data to Improve Healthcare: A Case Study of Pancreatic Enzyme Replacement in Pancreatic Cancer
Varghese, T., Andrews, C. D., Fisher, L., Goldacre, B. M., Mehrkar, A., Pandé, R., Smith, N. A. S., Walker, A. J., Roberts, K. J., Sultana, A., et al. (2024) · Seminars in Oncology Nursing · doi:10.1016/j.soncn.2024.151688
Risk factors to to monitor to facilitate early diagnosis of pancreatic cancer
Kanno, A., Tanaka, A., Sakurai, Y., Ikeda, E., Ando, K., Yokoyama, K., & Yamamoto, H. (2024) · Suizo · doi:10.2958/suizo.39.205
Insulin-dependence as a Predictor of Shortened Cancer-specific Survival in Pancreatic Neuroendocrine Tumors: A Multi-Institutional Study from the United States Neuroendocrine Study GroupPreprint
Mirza, M. B., Baechle, J. J., Smith, P. M., Ali, D., Dillhoff, M., Poultsides, G. A., Rocha, F. G., Cho, C. S., Winslow, E. R., Fields, R. C., et al. (2024) · medRxiv · doi:10.1101/2024.09.11.24313436
Diabetes Mellitus and Cancer
Daniel, J. M. M., Mathiazhagan, G., & Sathick, I. J. (2024) · Springer eBooks · doi:10.1007/978-981-97-6406-8_18
Diabetes in Diseases of the Exocrine Pancreas
Abramowitz, J. D., Gunasekaran, U., Samaropoulos, X. F., Tumyan, A., & Lingvay, I. (2018) · American Diabetes Association eBooks · doi:10.2337/9781580406666.ch04
Impact of race, sex and age on the probability of pancreatic cancer among patients with newly diagnosed diabetesPreprint
Afghani, E., Lau, B. M., Becker, L. K., Goggins, M., & Klein, A. P. (2024) · medRxiv · doi:10.1101/2024.12.13.24319002
New-Onset Diabetes as a Symptom of Pancreatic Adenocarcinoma
Gammoh, E., & Ullal, J. (2021) · doi:10.2337/9781580407663.case6
Early detection of pancreatic ductal adenocarcinoma
Illés, D. (2025) · doi:10.14232/phd.12286
Efficacy and Safety of a Continuous Intravenous Insulin Protocol Modified for East Asians in Postoperative Glycemic Management Following Pancreatectomy
Sasaki, H., Yagi, K., Kogure, R., Honda, M., & Kim, D. H. (2025) · Cureus · doi:10.7759/cureus.84527
New-onset type 2 diabetes mellitus complicated by diabetic ketoacidosis: a sentinel presentation of advanced pancreatic adenocarcinoma
Kazerouni, A. R., Ghahramani, S., Khayyer, Y., & Yousufzai, S. (2025) · Endocrinology Diabetes and Metabolism Case Reports · doi:10.1530/edm-25-0026
Are people with family history of pancreatic cancer enriched with genetic propensity for diabetes mellitus?
Egyin, S., Sosnowski, D. W., Orhin, A. E., Michaud, D. S., & Platz, E. A. (2026) · Annals of Cancer Epidemiology · doi:10.21037/ace-2025-11
Japanese nationwide prospective observational study on early pancreatic cancer screening in outpatients using a comprehensive scoring system and comparison with Western screening methods (EPSS-1)Preprint
Sagami, R., Yamao, K., Shimizu, A., Nishikiori, H., Yoshida, K., Yoshida, A., Takenaka, M., Imai, H., Sekine, K., Murakami, M., et al. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5413573
Patient with diabetes mellitus in the context of chronic pancreatitis: Some features of diagnosis and treatment
Lugovaya, L. A., Занозина, О. В., Анатольевна, Н. Т., Романовна, Б. У., & Александрович, А. Е. (2025) · FOCUS Endocrinology · doi:10.62751/2713-0177-2025-6-3-13
Epidemiology, Risk Factors and Clinical Presentation
Capurso, G., Hassan, C., Fave, G. D., & Giulio, E. D. (2010) · Medical radiology · doi:10.1007/174_2010_7
Additional file 8 of Construction of a prognostic model with histone modification-related genes and identification of potential drugs in pancreatic cancer
Chen, Y., Xu, R., Ruze, R., Yang, J., Wang, H., Song, J., You, L., Wang, C., & Zhao, Y. (2021) · Figshare · doi:10.6084/m9.figshare.14738790
Additional file 5 of Construction of a prognostic model with histone modification-related genes and identification of potential drugs in pancreatic cancer
Chen, Y., Xu, R., Ruze, R., Yang, J., Wang, H., Song, J., You, L., Wang, C., & Zhao, Y. (2021) · Figshare · doi:10.6084/m9.figshare.14738778
Additional file 7 of Construction of a prognostic model with histone modification-related genes and identification of potential drugs in pancreatic cancer
Chen, Y., Xu, R., Ruze, R., Yang, J., Wang, H., Song, J., You, L., Wang, C., & Zhao, Y. (2021) · Figshare · doi:10.6084/m9.figshare.14738787
Additional file 6 of Construction of a prognostic model with histone modification-related genes and identification of potential drugs in pancreatic cancer
Chen, Y., Xu, R., Ruze, R., Yang, J., Wang, H., Song, J., You, L., Wang, C., & Zhao, Y. (2021) · Figshare · doi:10.6084/m9.figshare.14738784
Additional file 11 of Construction of a prognostic model with histone modification-related genes and identification of potential drugs in pancreatic cancer
Chen, Y., Xu, R., Ruze, R., Yang, J., Wang, H., Song, J., You, L., Wang, C., & Zhao, Y. (2021) · Figshare · doi:10.6084/m9.figshare.14738760
Additional file 10 of Construction of a prognostic model with histone modification-related genes and identification of potential drugs in pancreatic cancer
Chen, Y., Xu, R., Ruze, R., Yang, J., Wang, H., Song, J., You, L., Wang, C., & Zhao, Y. (2021) · Figshare · doi:10.6084/m9.figshare.14738757
Additional file 12 of Construction of a prognostic model with histone modification-related genes and identification of potential drugs in pancreatic cancer
Chen, Y., Xu, R., Ruze, R., Yang, J., Wang, H., Song, J., You, L., Wang, C., & Zhao, Y. (2021) · Figshare · doi:10.6084/m9.figshare.14738763

Authors: Pannala, R., Leirness, J. B., Bamlet, W. R., Basu, A., Petersen, G. M., & Chari, S. T.
Affiliations: Mayo Clinic (US)
Corresponding author: Chari, Suresh T.
ORCID: Pannala, Rahul
Leirness, Jeffery B.
Bamlet, William R.
Basu, Ananda
Petersen, Gloria M.
Chari, Suresh T.
Venue: Gastroenterology
Publisher: Elsevier BV
Published: 2008-04
Volume: 134
Issue: 4
Pages: 981-987
ISSN: 0016-5085 (ISSN-L)
DOI: 10.1053/j.gastro.2008.01.039
PMC: PMC2323514
OpenAlex: W1998608669
Cited by: 621
References: 40
Citations by year: 2026: 25 · 2025: 45 · 2024: 32 · 2023: 50 · 2022: 40 · 2021: 59 · 2020: 47 · 2019: 42 · 2018: 39 · 2017: 36 · 2016: 20 · 2015: 29 · 2014: 35 · 2013: 26 · 2012: 38
FWCI: 10.03
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Gastroenterology (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Funders: National Cancer Institute (P50 CA 10270, P50CA102701, R01CA100685)
Topics: Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
Keywords: pancreatic cancer, diabetes mellitus, new-onset diabetes, pancreaticoduodenectomy, fasting blood glucose, body mass index, family history of diabetes, diabetes risk factors, cancer-associated diabetes
MeSH terms: Aged, Blood Glucose, Diabetes Mellitus, Female, Humans, Male, Neoplasm Staging, Pancreatic Neoplasms, Prospective Studies, Surveys and Questionnaires, Risk Factors, United States, Prevalence, Pancreaticoduodenectomy, Disease Progression

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Prevalence and Clinical Profile of Pancreatic Cancer–Associated Diabetes Mellitus

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks